title: The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.
abstract: Perhaps no other drug in modern medicine rivals the dramatic revitalization of thalidomide. Originally marketed as a sedative, thalidomide gained immense popularity worldwide among pregnant women because of its effective anti-emetic properties in morning sickness. Mounting evidence of human teratogenicity marked a dramatic fall from grace and led to widespread social, legal and economic ramifications. Despite its tragic past thalidomide emerged several decades later as a novel and highly effective agent in the treatment of various inflammatory and malignant diseases. In 2006 thalidomide completed its remarkable renaissance becoming the first new agent in over a decade to gain approval for the treatment of plasma cell myeloma. The catastrophic collapse yet subsequent revival of thalidomide provides important lessons in drug development. Never entirely abandoned by the medical community, thalidomide resurfaced as an important drug once the mechanisms of action were further studied and better understood. Ongoing research and development of related drugs such as lenalidomide now represent a class of irreplaceable drugs in hematological malignancies. Further, the tragedies associated with this agent stimulated the legislation which revamped the FDA regulatory process, expanded patient informed consent procedures and mandated more transparency from drug manufacturers. Finally, we review recent clinical trials summarizing selected medical indications for thalidomide with an emphasis on hematologic malignancies. Herein, we provide a historic perspective regarding the up-and-down development of thalidomide. Using PubMed databases we conducted searches using thalidomide and associated keywords highlighting pharmacology, mechanisms of action, and clinical uses.
authors.affiliation: Department of Medicine, Division of Hematology-Oncology, Case Comprehensive Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
authors.forename: Waqas
authors.initials: W
authors.lastname: Rehman
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Arfons
authors.forename: Hillard M
authors.initials: HM
authors.lastname: Lazarus
keywords: anti-angiogenic; anti-apoptosis; graft-versus-host disease; plasma cell myeloma; teratogenic
references.citation: N Engl J Med. 2000 Sep 28;343(13):972-3
references.pmid: 11012329
references.citation: N Engl J Med. 1992 Apr 16;326(16):1055-8
references.pmid: 1549151
references.citation: Br J Haematol. 2005 Dec;131(5):609-18
references.pmid: 16351636
references.citation: J Clin Oncol. 2002 Nov 1;20(21):4319-23
references.pmid: 12409330
references.citation: Br J Haematol. 2004 Apr;125(1):96-7
references.pmid: 15015981
references.citation: Ann Intern Med. 1998 Mar 15;128(6):443-50
references.pmid: 9499327
references.citation: Leuk Res. 2004 Apr;28(4):325-32
references.pmid: 15109529
references.citation: AIDS. 1996 Nov;10(13):1501-7
references.pmid: 8931784
references.citation: J Clin Oncol. 2003 Jan 1;21(1):16-9
references.pmid: 12506164
references.citation: Nat Med. 2010 Apr;16(4):420-8
references.pmid: 20364125
references.citation: Haematologica. 2010 Mar;95(3):456-63
references.pmid: 19815837
references.citation: Br J Pharmacol Chemother. 1965 Oct;25(2):338-51
references.pmid: 5866716
references.citation: J Clin Oncol. 2009 Aug 1;27(22):3664-70
references.pmid: 19451428
references.citation: Lancet Oncol. 2010 Oct;11(10):934-41
references.pmid: 20739218
references.citation: J Clin Oncol. 2005 Aug 10;23(23):5334-46
references.pmid: 15939924
references.citation: Am J Med. 2002 Apr 1;112(5):412-3
references.pmid: 11904117
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3510-7
references.pmid: 19546405
references.citation: Br J Haematol. 2003 Jun;121(5):768-71
references.pmid: 12780791
references.citation: Mayo Clin Proc. 2004 Jul;79(7):899-903
references.pmid: 15244387
references.citation: N Engl J Med. 1997 May 22;336(21):1487-93
references.pmid: 9154767
references.citation: Blood. 2010 Oct 7;116(14):2429-37
references.pmid: 20581310
references.citation: Eur J Haematol. 2007 Apr;78(4):297-302
references.pmid: 17286608
references.citation: Lepr Rev. 1965 Oct;36(4):183-7
references.pmid: 5871249
references.citation: Eur J Haematol. 2008 Oct;81(4):247-52
references.pmid: 18637031
references.citation: J Pediatr. 2004 Dec;145(6):856-7
references.pmid: 15580219
references.citation: Am J Hematol. 2009 Oct;84(10):698-9
references.pmid: 19691102
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4082-5
references.pmid: 7513432
references.citation: Lancet. 2004 May 29;363(9423):1802-11
references.pmid: 15172781
references.citation: Br J Haematol. 2005 Jun;129(6):763-70
references.pmid: 15953002
references.citation: N Engl J Med. 2007 Nov 22;357(21):2123-32
references.pmid: 18032762
references.citation: N Engl J Med. 2007 Nov 22;357(21):2133-42
references.pmid: 18032763
references.citation: Gastroenterology. 1999 Dec;117(6):1278-87
references.pmid: 10579968
references.citation: J Exp Med. 1993 Jun 1;177(6):1675-80
references.pmid: 8496685
references.citation: Teratology. 1988 Sep;38(3):221-6
references.pmid: 3227491
references.citation: N Engl J Med. 1997 Apr 10;336(15):1066-71
references.pmid: 9091804
references.citation: Br J Haematol. 2008 Jun;141(6):814-9
references.pmid: 18410447
references.citation: Aliment Pharmacol Ther. 2007 Feb 15;25(4):419-27
references.pmid: 17269997
references.citation: CA Cancer J Clin. 2010 Jul-Aug;60(4):222-43
references.pmid: 20554717
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3596-601
references.pmid: 11504741
references.citation: Blood Coagul Fibrinolysis. 2002 Apr;13(3):187-92
references.pmid: 11943931
references.citation: Lancet. 2010 Dec 18;376(9758):2075-85
references.pmid: 21146205
references.citation: Blood. 2008 Dec 1;112(12):4452-7
references.pmid: 18713945
references.citation: Clin Lymphoma Myeloma. 2009 Aug;9(4):320-3
references.pmid: 19717384
references.citation: Blood. 2010 Jul 8;116(1):22-6
references.pmid: 20339094
references.citation: N Engl J Med. 2006 Mar 9;354(10):1021-30
references.pmid: 16525139
references.citation: Biol Blood Marrow Transplant. 1996 May;2(2):86-92
references.pmid: 9118303
references.citation: Leukemia. 2011 Apr;25(4):689-96
references.pmid: 21233832
references.citation: J Exp Med. 1998 Jun 1;187(11):1885-92
references.pmid: 9607928
references.citation: J Support Oncol. 2003 Sep-Oct;1(3):194-205
references.pmid: 15334875
references.citation: J R Soc Med. 2004 Sep;97(9):443
references.pmid: 15340031
references.citation: Br J Haematol. 2006 Aug;134(4):399-405
references.pmid: 16882132
references.citation: Blood. 2001 Jul 15;98(2):492-4
references.pmid: 11435324
references.citation: J Clin Oncol. 2001 Aug 15;19(16):3593-5
references.pmid: 11504740
references.citation: Clin Ther. 1999 Feb;21(2):319-30
references.pmid: 10211535
references.citation: Leuk Lymphoma. 2007 Jan;48(1):46-55
references.pmid: 17325847
references.citation: J Clin Oncol. 2009 Apr 10;27(11):1788-93
references.pmid: 19273705
references.citation: Eur J Haematol. 2007 Sep;79(3):234-9
references.pmid: 17655699
references.citation: Nat Med. 2010 Apr;16(4):370-2
references.pmid: 20376039
references.citation: Gut. 2002 Feb;50(2):196-200
references.pmid: 11788559
references.citation: Drugs. 2000 Aug;60(2):273-92
references.pmid: 10983733
references.citation: Neurology. 2002 Dec 24;59(12):1872-5
references.pmid: 12499476
references.citation: J Biol Chem. 2001 Jun 22;276(25):22382-7
references.pmid: 11297551
references.citation: Clin Pharmacol Ther. 1965 May-Jun;6:292-7
references.pmid: 14296025
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):817-25
references.pmid: 21277098
references.citation: Blood. 2003 Jul 1;102(1):69-77
references.pmid: 12637329
references.citation: Br J Haematol. 2008 Feb;140(3):313-9
references.pmid: 18217897
references.citation: Blood. 2010 Sep 2;116(9):1405-12
references.pmid: 20448107
references.citation: Eur J Clin Pharmacol. 2001 Aug;57(5):365-76
references.pmid: 11599654
references.citation: J Clin Oncol. 2009 Jan 1;27(1):120-6
references.pmid: 19047284
references.citation: Blood. 1995 Nov 1;86(9):3604-9
references.pmid: 7579470
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2070-6
references.pmid: 20308663
references.citation: Br J Haematol. 2009 Mar;144(5):653-9
references.pmid: 19036082
references.citation: Exp Eye Res. 1997 Jun;64(6):971-8
references.pmid: 9301478
references.citation: Gynecol Oncol. 2010 Dec;119(3):444-50
references.pmid: 20846715
references.citation: Blood. 2010 Feb 11;115(6):1113-20
references.pmid: 19880501
references.citation: J Clin Oncol. 2000 Jul;18(13):2593-602
references.pmid: 10893291
references.citation: J Clin Oncol. 2002 Jan 1;20(1):302-6
references.pmid: 11773183
references.citation: Clin Exp Immunol. 1995 Feb;99(2):160-7
references.pmid: 7851006
references.citation: J Peripher Nerv Syst. 2008 Dec;13(4):275-82
references.pmid: 19192067
references.citation: Pediatrics. 2002 Aug;110(2 Pt 1):404-6
references.pmid: 12165600
references.citation: Blood. 2001 Sep 1;98(5):1614-5
references.pmid: 11520815
references.citation: Leukemia. 2010 Nov;24(11):1934-9
references.pmid: 20827286
references.citation: J Thromb Haemost. 2011 Apr;9(4):653-63
references.pmid: 21255254
references.citation: Can J Gastroenterol. 2009 Sep;23(9):625-31
references.pmid: 19816627
references.citation: J Clin Oncol. 2004 Aug 15;22(16):3212-4
references.pmid: 15249587
references.citation: Bull World Health Organ. 1971;45(6):719-32
references.pmid: 4947831
references.citation: J Clin Oncol. 2006 Jan 20;24(3):431-6
references.pmid: 16365178
references.citation: Cancer. 2006 Aug 15;107(4):767-72
references.pmid: 16826578
references.citation: Blood. 2010 Jan 21;115(3):605-14
references.pmid: 19965623
references.citation: Br J Haematol. 2003 Jul;122(1):160-1
references.pmid: 12823359
references.citation: Leuk Lymphoma. 2005 Feb;46(2):239-42
references.pmid: 15621807
references.citation: N Engl J Med. 2006 Oct 5;355(14):1456-65
references.pmid: 17021321
references.citation: J Pharmacokinet Biopharm. 1998 Aug;26(4):363-83
references.pmid: 10214558
references.citation: Onco Targets Ther. 2010 Jun 24;3:69-82
references.pmid: 20616958
references.citation: Haematologica. 2010 Sep;95(9):1548-54
references.pmid: 20418244
references.citation: J Clin Oncol. 2009 Oct 10;27(29):4865-73
references.pmid: 19704059
references.citation: N Engl J Med. 1962 Dec 6;267:1184-92 contd
references.pmid: 13934699
references.citation: Mayo Clin Proc. 2004 Jul;79(7):875-82
references.pmid: 15244383
references.citation: Biol Blood Marrow Transplant. 2001;7(5):265-73
references.pmid: 11400948
references.citation: Leuk Lymphoma. 2007 Oct;48(10):1940-9
references.pmid: 17917962
references.citation: Br J Pharmacol Chemother. 1965 Oct;25(2):324-37
references.pmid: 5866715
references.citation: Leuk Res. 2007 Feb;31(2):253-6
references.pmid: 16815546
references.citation: Lancet Oncol. 2010 Jan;11(1):29-37
references.pmid: 19853510
references.citation: Clin Pharmacol Ther. 1965 May-Jun;6:298-302
references.pmid: 14296026
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: J Clin Oncol. 2011 Mar 1;29(7):797-804
references.pmid: 21245421
references.citation: Mayo Clin Proc. 2004 Jul;79(7):883-9
references.pmid: 15244384
references.citation: Lancet. 2007 Oct 6;370(9594):1209-18
references.pmid: 17920916
references.citation: Haemophilia. 2009 Nov;15(6):1340-2
references.pmid: 19702883
references.citation: N Engl J Med. 1999 Nov 18;341(21):1565-71
references.pmid: 10564685
references.citation: Biochem Pharmacol. 1998 Jun 1;55(11):1827-34
references.pmid: 9714301
references.citation: Ann Hematol. 2004 Sep;83(9):588-91
references.pmid: 15235749
references.citation: N Engl J Med. 1962 Dec 13;267:1238-44 concl
references.pmid: 13934700
references.citation: J Hematol Oncol. 2009 Aug 12;2:36
references.pmid: 19674465
references.citation: J Clin Oncol. 2010 Jul 1;28(19):3160-6
references.pmid: 20516439
references.citation: Leukemia. 2011 Feb;25(2):301-4
references.pmid: 21052089
references.citation: Swiss Med Wkly. 2003 Feb 8;133(5-6):77-87
references.pmid: 12644961
references.citation: Am J Hematol. 2010 Feb;85(2):95-6
references.pmid: 20095057
references.citation: Blood. 2002 Jun 15;99(12):4525-30
references.pmid: 12036884
references.citation: J Rheumatol. 2003 Dec;30(12):2627-31
references.pmid: 14719205
references.citation: Br J Haematol. 2006 Mar;132(5):584-93
references.pmid: 16445831
references.citation: Am J Hematol. 2011 Jan;86(1):57-65
references.pmid: 21181954
references.citation: J Clin Oncol. 2011 Mar 10;29(8):986-93
references.pmid: 21282540
references.citation: Thromb Haemost. 2005 Dec;94(6):1341-3
references.pmid: 16411420
references.citation: Mayo Clin Proc. 2003 Jan;78(1):34-9
references.pmid: 12528875
references.citation: Can J Gastroenterol. 2006 Mar;20(3):171-8
references.pmid: 16550261
references.citation: Chirality. 1996;8(5):390-6
references.pmid: 8900028
references.citation: Teratology. 1988 Sep;38(3):203-15
references.pmid: 3067415
references.citation: Clin Pharmacokinet. 2004;43(5):311-27
references.pmid: 15080764
references.citation: Gut. 2004 Apr;53(4):609-12
references.pmid: 15016759
references.citation: Clin Pharmacol Ther. 1965 May-Jun;6:303-6
references.pmid: 14296027
references.citation: J Clin Oncol. 2004 Feb 1;22(3):424-31
references.pmid: 14752066
references.citation: Haematologica. 2007 Feb;92(2):279-80
references.pmid: 17296591
references.citation: Cancer. 2006 May 1;106(9):1974-84
references.pmid: 16583431
references.citation: Blood. 2002 Aug 15;100(4):1168-71
references.pmid: 12149193
references.citation: J Infect Dis. 1991 Nov;164(5):990-3
references.pmid: 1940481
references.citation: Science. 2010 Mar 12;327(5971):1345-50
references.pmid: 20223979
references.citation: Blood. 2008 Aug 15;112(4):1035-8
references.pmid: 18502827
references.citation: Int J Hematol. 2009 Jan;89(1):76-79
references.pmid: 19052692
references.citation: J Clin Oncol. 2008 May 1;26(13):2171-7
references.pmid: 18362366
references.citation: Leuk Lymphoma. 2009 Apr;50(4):588-92
references.pmid: 19373657
references.citation: Blood. 2000 Nov 1;96(9):2943-50
references.pmid: 11049970
references.citation: Lancet. 1962 Apr 28;1(7235):912-3
references.pmid: 13915092
references.citation: J Pharm Sci. 1999 Jan;88(1):121-5
references.pmid: 9874712